RVNC
Revance Therapeutics Inc
Price:  
6.98 
USD
Volume:  
3,590,005.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RVNC WACC - Weighted Average Cost of Capital

The WACC of Revance Therapeutics Inc (RVNC) is 9.3%.

The Cost of Equity of Revance Therapeutics Inc (RVNC) is 10.80%.
The Cost of Debt of Revance Therapeutics Inc (RVNC) is 7.00%.

Range Selected
Cost of equity 8.50% - 13.10% 10.80%
Tax rate 0.10% - 0.50% 0.30%
Cost of debt 7.00% - 7.00% 7.00%
WACC 7.9% - 10.7% 9.3%
WACC

RVNC WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.01 1.46
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.50% 13.10%
Tax rate 0.10% 0.50%
Debt/Equity ratio 0.62 0.62
Cost of debt 7.00% 7.00%
After-tax WACC 7.9% 10.7%
Selected WACC 9.3%